HCL-FOUNDATION
16.2.2021 11:37:15 CET | Business Wire | Press release
HCL Foundation, the corporate social responsibility arm of HCL Technologies Ltd., today announced the winners of the sixth round of the HCL Grant, a flagship program dedicated to strengthening India’s “fifth estate” of NGOs working towards nation building.
The three NGOs, one each in the development areas of environment, health, and education, will each receive a grant of INR 5 crore ($685,000) for a three to five-year project. In addition, two finalists in each category will receive a one-year grant of INR 25 lakhs ($34,000), making a total grant of INR 16.5 crore.
HCL Foundation, which this year celebrates a decade of building strong and robust communities, is committed to contributing to the nation’s growth curve. Under its HCL Grant program, the Foundation has so far committed a more than INR 60 crore ($8.26 Million), excluding this year’s grants. Recognized as one of the most sought-after validations amongst NGO ecosystems in India, the HCL Grant has in the past five years reached over 733,000 beneficiaries. The Grant aims to touch the lives of at least 1.72 million people in 8,598 villages in 70 districts across 18 states and two union territories of India.
The winning NGOs of HCL Grant 2021 were:
- Saahas (Environment)
- India Health Action Trust (Health)
- Child Rights and You (Education)
The NGOs were chosen after an 8-month review of thousands of applications by an eminent jury, monitored and audited by Grant Thornton, the governance partner of HCL Grant. The jury consisted of: Ms. Robin Abrams, Director, HCL Technologies, and Chairperson of the jury; Mr. Suresh Narayanan, Chairman and Managing Director, Nestle India Limited; Mr. B. S. Baswan, former Director, Indian Institute of Public Administration, and former Secretary, Human Resource Development ministry; Ms. Pallavi Shroff, Managing Partner, Shardul Amarchand Mangaldas & Co. law firm; Dr. Richard Lariviere, President Emeritus, Field Museum (Chicago), and former President, University of Oregon; and Mr. Shiv Nadar, Founder of HCL, Chief Strategy Officer of HCL Technologies, and Founder and Chairman of the Shiv Nadar Foundation.
“The past year was a unique year of resilience and transformation that taught us how to transcend barriers and keep going even in the face of adversity,” said Ms. Abrams. “Despite the pandemic, the robustness demonstrated by our NGO partners, experts, jury members and the entire team is commendable. The passion and zeal of our NGO partners to bring in scalable and replicable solutions have created systemic shifts across geographies, lending velocity to the sustainable development agenda. The winners and finalists of this year’s Grant also have significant stories to tell, with visible on-the-ground impact. My best wishes to these NGOs, who are addressing some of the most pressing issues in the key development categories of environment, health, and education in the most remote corners of the country.”
Ms. Nidhi Pundhir, Director, HCL Foundation, said: “The year 2020 has been both special and unusual. Special, in that the Foundation is completing ten years of facilitating high-impact, sustainable socio-economic development in rural India. Unusual, in that the NGOs we support had to deal with unprecedented challenges posed by the pandemic and various natural disasters, while initiating and implementing their developmental projects. What is inspiring about these NGOs is that they are treating COVID-19 as the ‘new normal’ and are continuing with their path-breaking projects without a pause, creating a much-needed last-mile support framework.”
On the occasion of the grant awards, the HCL Foundation released “Fifth Estate – NGOs Transforming Rural India in Environment, Health and Education,” a compendium featuring the top 30 NGOs selected in the sub-jury round, as well as the previous year’s winning NGOs.
For more information please visit www.hclfoundation.org/hcl-grant
View source version on businesswire.com: https://www.businesswire.com/news/home/20210216005593/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 115.10.2026 02:30:00 CEST | Press release
− ORZEYFUL is now available in Japan and China following approvals within a month of each other by China’s National Medical Products Administration (NMPA), the U.S. Food and Drug Administration (FDA) and Japan’s Ministry of Health, Labour and Welfare (MHLW) − Discovered by Takeda scientists in Japan, ORZEYFUL is the lead medicine in Takeda’s orexin franchise, with multiple programs for sleep-wake disorders and conditions where orexin biology plays a role − ORZEYFUL set to launch next month in the U.S., following completion of DEA scheduling; Health Authority submissions underway worldwide Takeda (TSE:4502/NYSE:TAK)announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the underlying orexin deficiency associated with NT1. “We’re ex
Celltrion to Spotlight Subcutaneous (SC) Infliximab (Remsima™ SC) and Broader IBD Portfolio at UEG Week 202615.10.2026 02:10:00 CEST | Press release
Celltrion to showcase its broad IBD portfolio, including Remsima™ IV, Remsima™ SC, the newly launched Remsima™ IV Liquid formulation, Steqeyma™ and Yuflyma™Symposium and Meet the Experts sessions to highlight long-term clinical evidence and real-world experience with subcutaneous (SC) infliximab (Remsima™ SC) across different IBD patient scenarios Celltrion, Inc. (KRX:068270) announced its participation in United European Gastroenterology (UEG) Week 2026, in Barcelona, Spain (Oct. 17-20), highlighting its inflammatory bowel disease (IBD) treatment portfolio, led by Remsima™ SC (subcutaneous infliximab). Celltrion will showcase its comprehensive infliximab portfolio, comprising Remsima™ intravenous (IV) and subcutaneous (SC) formulations, as well as the Remsima™ IV liquid formulation launched in Europe earlier this year.1 Additionally, the company will highlight its broader IBD portfolio, including SteQeyma™ (ustekinumab) and Yuflyma™ (adalimumab), reflecting its continued efforts to ex
ProcureTEX Returns for Its Second Year, Bringing AI and Best-of-Breed Procurement Technology to Amsterdam14.10.2026 18:26:00 CEST | Press release
Founding partners Beroe, Keelvar and Zip bring back the community-driven event with a practitioner-shaped agenda spanning real-world AI use and the future of procurement ProcureTEX, the community-driven event for best-of-breed procurement technology, returns for its second year on November 3, 2026, at Circa in Amsterdam. Following its London debut in 2025, the event sharpens its focus on how AI is reshaping procurement. It will bring together over 250 procurement leaders and digital transformation teams from large enterprises, with vetted best-of-breed technology providers, to see AI agents and interoperable tools working together on real enterprise challenges. Co-founded by Beroe, Keelvar and Zip, the event is built on the belief that the future of procurement isn’t a monolithic all-in-one suite, but an ecosystem of best-of-breed tools working together. It is designed for procurement and enterprise leaders seeking scalable, modern solutions, whether they’re driving transformation, fru
eM Client 11 Launches: A European Outlook Alternative Bringing AI Freedom, Digital Sovereignty, and Next-Generation Productivity14.10.2026 18:16:00 CEST | Press release
eM Client, the European developer of the popular email and productivity application used by millions worldwide, today announced the release of eM Client 11, its most significant update yet. The new version introduces advanced AI capabilities, and major productivity improvements, strengthening its position as an independent alternative to Microsoft Outlook. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014945464/en/ eM Client 11 main window AI Without Vendor Lock-In eM Client 11 introduces a powerful AI Assistant that enables users to search, summarize, organize, and manage emails using natural language. Additional features include personalized AI writing, context-aware quick replies, automatic task and event detection, and AI-powered email rules. Unlike traditional AI integrations, eM Client 11 supports Bring Your Own Key (BYOK), allowing organizations to connect compatible AI providers and models of their choice. The re
iQmetrix and Stratus HR Partner to Give Wireless Retailers a Complete, Outsourced HR Department14.10.2026 17:15:00 CEST | Press release
New integration connects the employee lifecycle to the store – new hires, terminations, rehires, position moves, and security-role updates flow straight into the POS, with payroll, benefits, and compliance handled by Stratus HR’s certified experts. Stratus HR, a full-service human resources outsourcing provider, today announced a partnership with iQmetrix, the Intelligent Commerce Operating System for telecom. As a Professional Employer Organization (PEO), Stratus HR becomes the complete, outsourced HR partner for wireless retailers on iQmetrix – payroll, benefits, compliance, and on-call HR experts – so retail teams stay focused on selling and serving customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014178512/en/ Fully integrated with iQmetrix, Stratus HR’s custom-built technology connects the employee lifecycle to the store: new hires, terminations, rehires, position moves, and security-role updates flow straig
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
